Skip to content

Effects of Balloon-blowing Exercises With Abdominal & Lumbar Core Muscle Activation Position Among Smokers

Effects of Balloon-blowing Exercises With Abdominal & Lumbar Core Muscle Activation Position Among Smokers

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06671288
Enrollment
21
Registered
2024-11-04
Start date
2024-08-15
Completion date
2025-02-01
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

dysnea, Cigarette smoking, spirometry, Quality of life

Brief summary

The principle function of the lungs is the facilitation of the gaseous exchange, commonly referred as respiratory or breathing. Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health.Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health. Cigarette smoking is linked to mild airway obstruction and a deceleration in the growth of lung function.Performing balloon-blowing exercises with abdominal and lumbar core muscles activation position leads to an improvement on pulmonary function and quality of life in smokers.

Detailed description

Cigarette smoking has detrimental effects on nearly every organ in the body, leading to a higher incidence of diseases and contributing to a gradual deterioration of the smoker's health, including a progressive impairment of lung function. Cigarette smoking is linked to mild airway obstruction and a deceleration in the growth of lung function. Smokers may experience inflammation and narrowing of their airways, resulting in increased resistance to the outward flow of air during exhalation. This restriction in airflow can negatively impact respiratory parameters, exercise tolerance, and overall quality of life. Performing balloon-blowing exercises with abdominal and lumbar core muscles activation position leads to an improvement on pulmonary function and quality of life in smokers.

Interventions

OTHERBalloon-blowing exercises with abdominal & lumbar core muscle activation position.

Patients in this group will recieve Balloon-blowing exercises with abdominal and lumbar core muscles activation position Total 4 weeks protocol will be followed in which 3 sessions per week will be supervised by physical therapist. FREQUENCY: 3 times a week, INTENSITY : Moderate, TIME: 4 sets of balloon-blowing with 1 min rest (30 mins) TYPE: Balloon-blowing with abdominal & lumbar core muscle activation position, DURATION : 4 weeks

Participants in this group will only be receiving diaphragmatic breathing exercise for 4 weeks. FREQUENCY: 3 times a week , INTENSITY: Moderate, TIME: 4 sets of diaphragmatic breathing with 1 min rest, TYPE: Diaphragmatic breathing, DURATION: 4 weeks

Sponsors

Foundation University Islamabad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a randomized controlled trial having two groups. One group will receive (interventional group) balloon-blowing exercises with abdominal & lumbar core muscles activation position. and the other group (control group) will receive Diaphragmatic breathing exercise.

Eligibility

Sex/Gender
ALL
Age
25 Years to 59 Years
Healthy volunteers
No

Inclusion criteria

* Adults: aged (25-59 years) * Gender: Both males and females * Grade1- Grade 4 on Modified MRC dyspnea scale * COPD classes (mild, moderate ) according to GOLD COPD Guidelines * Participating voluntarily and follow the instructions & performing * The number of packs of cigarettes smoked per day by the number of years the person has smoked. 1. pack yr = 20 cig/day x 1 yrs 2. pack yr = 20 cig/day x 2 yrs

Exclusion criteria

* Severe cases of obstruction like Severe asthma & status asthmaticus, Severe COPD, bullous emphysema for pneumothorax. * Any congenital deformities of chest wall, Demonstrated neuromuscular or neurological deficit/disease of chest wall * Other serious Cardiopulmonary diseases including pulmonary embolism, pulmonary ----Hypertension, Active TB, pneumonias or other acute illnesses * Any recent cardiothoracic or abdominal surgery, trauma or injury * Pregnancy * Any psychiatric illnesses

Design outcomes

Primary

MeasureTime frameDescription
FVC (forced vital capacity):4 weeksFVC (forced vital capacity): The amount of air that can be maximum forcefully be exhaled after taking deep breath.
FEV14 weeksFEV1(Forced expiratory volume in 1 second): The volume of air that is forcefully exhaled in one second.
FEV1/FVC4 weeksFEV1/FVC: The ratio of the forced expiratory volume in the first one second to the forced vital capacity of the lungs.
PEF (Peak expiratory flow)4 WeeksPEF( Peak expiratory flow): Measurement of the highest speed at which a individual can exhale air from their lungs after a full inhalation.
Dyspnea4 WeeksEvaluation will be done using mMRC dyspnea scale (0-4). 0 I only get breathless with strenuous exercise 1. I get short of breath when hurrying on level ground or walking up a slight hill 2. On level ground, I walk slower than people of the same age because of breathlessness, or have to stop for breath when walking at my own pace 3. I stop for breath after walking about 100 yards \[91 meters\] or after a few minutes on level ground 4. I am too breathless to leave the house or I am breathless when dressing
Quality of life of participant4 weeksQuality of life questionnaire (SF-36) will be used to evaluate smokers QOLSF-36 Questionnaire (0-100). Each question carries equal weight the lower the score the more the disability. The higher the score the lesser the disability. 0: Maximum disability 100: No disability
Oxygen saturation4 weeksPulse oximeter will be used to measure oxygen saturation

Countries

Pakistan

Contacts

Primary ContactTooba Shahbaz, MS-CPT*
tshahbaz59@gmail.com0340-5416747

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026